ES8601966A1 - Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona. - Google Patents

Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona.

Info

Publication number
ES8601966A1
ES8601966A1 ES536286A ES536286A ES8601966A1 ES 8601966 A1 ES8601966 A1 ES 8601966A1 ES 536286 A ES536286 A ES 536286A ES 536286 A ES536286 A ES 536286A ES 8601966 A1 ES8601966 A1 ES 8601966A1
Authority
ES
Spain
Prior art keywords
antidepressant
triazolone compounds
compounds
triazolone
phenoxyalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES536286A
Other languages
English (en)
Spanish (es)
Other versions
ES536286A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24145128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8601966(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES536286A0 publication Critical patent/ES536286A0/es
Publication of ES8601966A1 publication Critical patent/ES8601966A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES536286A 1983-09-30 1984-09-27 Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona. Expired ES8601966A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,027 US4613600A (en) 1983-09-30 1983-09-30 Antidepressant 1,2,4-triazolone compounds

Publications (2)

Publication Number Publication Date
ES536286A0 ES536286A0 (es) 1985-11-16
ES8601966A1 true ES8601966A1 (es) 1985-11-16

Family

ID=24145128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536286A Expired ES8601966A1 (es) 1983-09-30 1984-09-27 Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona.

Country Status (25)

Country Link
US (1) US4613600A (en:Method)
JP (1) JPS60100560A (en:Method)
KR (1) KR880002624B1 (en:Method)
AT (1) AT387963B (en:Method)
AU (1) AU561460B2 (en:Method)
BE (1) BE900714A (en:Method)
CA (1) CA1237723A (en:Method)
CH (1) CH661924A5 (en:Method)
CY (1) CY1541A (en:Method)
DE (1) DE3435745C2 (en:Method)
DK (1) DK169546B1 (en:Method)
ES (1) ES8601966A1 (en:Method)
FI (1) FI83310C (en:Method)
FR (1) FR2552759B1 (en:Method)
GB (1) GB2147297B (en:Method)
GR (1) GR80475B (en:Method)
HK (1) HK37391A (en:Method)
IE (1) IE58084B1 (en:Method)
IT (1) IT1178522B (en:Method)
LU (1) LU85561A1 (en:Method)
MY (1) MY102123A (en:Method)
NL (1) NL8402946A (en:Method)
SE (1) SE465928B (en:Method)
YU (1) YU45667B (en:Method)
ZA (1) ZA847589B (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
JP2002541192A (ja) * 1999-04-09 2002-12-03 セプラコール， インク． Ｓ−ヒドロキシネファゾドン
AU4215300A (en) * 1999-04-09 2000-11-14 Sepracor, Inc. R-hydroxynefazodone
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20050233010A1 (en) * 2004-04-19 2005-10-20 Satow Philip M Lithium combinations, and uses related thereto
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
WO2009111031A2 (en) * 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
CN104208718B (zh) 2009-02-20 2017-12-29 2-Bbb医疗股份有限公司 基于谷胱甘肽的药物递送系统
KR20190116576A (ko) 2009-05-06 2019-10-14 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
WO2013036830A1 (en) * 2011-09-09 2013-03-14 The Board Of Trustees Of The Leland Standford Junior University Topical itraconazole formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
SE8404869L (sv) 1985-03-31
SE465928B (sv) 1991-11-18
DE3435745A1 (de) 1985-04-11
YU45667B (sh) 1992-07-20
IT8422922A0 (it) 1984-09-28
YU172184A (en) 1986-10-31
FR2552759B1 (fr) 1988-10-07
KR850002270A (ko) 1985-05-10
JPS60100560A (ja) 1985-06-04
FI83310C (fi) 1991-06-25
GR80475B (en) 1985-01-31
IT1178522B (it) 1987-09-09
BE900714A (fr) 1985-03-28
MY102123A (en) 1992-03-31
DE3435745C2 (de) 1994-11-03
ES536286A0 (es) 1985-11-16
SE8404869D0 (sv) 1984-09-28
HK37391A (en) 1991-05-24
AT387963B (de) 1989-04-10
GB2147297B (en) 1987-04-15
JPH0542435B2 (en:Method) 1993-06-28
GB2147297A (en) 1985-05-09
DK468284D0 (da) 1984-09-28
KR880002624B1 (ko) 1988-12-07
NL8402946A (nl) 1985-04-16
CA1237723A (en) 1988-06-07
FR2552759A1 (fr) 1985-04-05
IE842476L (en) 1985-03-30
CH661924A5 (de) 1987-08-31
AU3364884A (en) 1985-04-04
IE58084B1 (en) 1993-06-30
AU561460B2 (en) 1987-05-07
FI843779L (fi) 1985-03-31
FI843779A0 (fi) 1984-09-26
ATA310884A (de) 1988-09-15
CY1541A (en) 1991-03-22
DK169546B1 (da) 1994-11-28
ZA847589B (en) 1985-05-29
LU85561A1 (fr) 1985-06-04
GB8424535D0 (en) 1984-11-07
FI83310B (fi) 1991-03-15
DK468284A (da) 1985-03-31
US4613600A (en) 1986-09-23

Similar Documents

Publication Publication Date Title
ES8601966A1 (es) Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona.
DK89595A (da) Fremgangsmåde til fremstilling af 1-(3-dimethylaminopropyl)-1'-(4-fluorphenyl)-1,3-dihydroisobenzofuran-5-carbonnitril
TR200001603T2 (tr) Yeni bileşikler
TR200000014T2 (tr) Yeni ikameli imidazol bileşimleri.
YU81091A (sh) Analozi 5-(1-hidroksi-2-piperidinopropil)-2-(1h,3h)-indolona
ES2062403T3 (es) 5-((tetrazolil)-alquenil)-imidazoles sustituidos.
SE8600174L (sv) Nytt forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkylazaspiroalkandioner
BG106930A (en) Substituted phenyl-piperazine derivatives, their preparation and use
ES8601923A1 (es) Procedimiento para la obtencion de n-sulfonil-n'pirimidil- y -triacinil-ureas
ATE240321T1 (de) 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität
DE69106199D1 (de) Heterocyclische Acetonitrile und ihre Verwendung als Fungizide.
AR227542A1 (es) Procedimiento para preparar derivados de 4-(4-amino-6,7-dimetoxi-quinazolin-2-il)-1-(2,4-dioxo-2,2,3,4-tetrahidro-pirimidin-6-il)-piperazina
KR960016716A (ko) 테트라졸리논
IT8421471A0 (it) Dro-1h-1,4-diazepina ad attivita'derivato di 1-[bis-(4-fluorofenil)calcio antagonista, sua preparaziometil]-4-(3-fenil-2-propenil)-esaine e composizioni che lo contengono
TR199700547A2 (xx) N-asetonilbenzamid fungisitler.
ES2001809A6 (es) Un procedimiento para la preparacion de nuevas 3-(4,-fenil-piperazinil)alquil-quinazolin-2,4-(1h,3h)-dionas sustituidas
KR940005592A (ko) 살균제(2- 아릴- 2- 치환)에틸-1, 2, 4- 트리아졸들
KR970702275A (ko) 1-[5-메탄설폰아미도인돌릴-2-카보닐1-4-[3- -2-피리디 닐]피페라진의 신규한 결정 형태(NOVEL CRYSTAL FORMS OF 1-[5- METHANESULFONAMIDOlNDOLYL-2-CARBONYL]-4-[3-(1-METHYL- ETHYLAMINO)-2-PYRIDINYL]PIPERAZINE
ATE28865T1 (de) Benzoylharnstoff-verbindungen als schaedlingsbekaempfungsmittel.
IL71859A (en) 3-(1,3-dioxolan-2-yl)-pyridine derivatives,their production and their use as microbicides
DE59806444D1 (de) Phenylketiminooxybenzylverbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE69940922D1 (de) Polymorphe Form B von 3-(Cyclopropylmethoxy)-4-i4-(methylsulfonyl)phenyl -5,5-dimethyl-5H-furan-2-on
DK0812842T3 (da) Fremgangsmåde til fremstilling af 5-(alkoxymethyl)-2,3-pyridindicarboximidforbindelser
EP0174584A3 (de) Salicylamid-Derivate
ATE194004T1 (de) Polymorphe a und b des 1-(piphenylmethyl)-4-(3-(2-phenyl-dioxolan-2-yl propyl)piperazins

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050709